MediciNova, Inc. (MNOV) - NASDAQ
  • bakerbros | Send Message 26 Apr

    nothing but selling $MNOV
    Reply
      • anomaly1 | Send Message 25 Apr

        $MNOV headed to $5
        Reply
          • anomaly1 | Send Message 20 Apr

            $MNOV in $5 range when announcement of interim data presentation was made... next ALS trial conclusion in DEC 2017
            Reply
              • bakerbros | Send Message 20 Apr

                $MNOV will it have support at $5 ??? the submarine is diving fast
                Reply
                  • bakerbros | Send Message 20 Apr

                    CEO announces totally USELESS info to support ALS trial . Useless data = Strong SELL $MNOV
                    Reply
                      • bakerbros | Send Message 18 Apr

                        like I said... shorted $MNOV from $10
                        Reply
                          • bakerbros | Send Message 18 Apr

                            MN-166 study was for 1 week stabilization + 1.5 week testing. inconclusive and data limited to subjective questions $MNOV Strong Sell
                            Reply
                              • wilkinson99 | Send Message 18 Apr

                                Premarket Top % Gainers: $CVT 66%, $RXDX 17%, $FCSC 13%, $DRIP 12%, $IMMU 12%, $DWTI 11%, $GASX 10% $BIOC $RUSS $SCO $NM $ERY $ORPN $MNOV
                                Reply
                                  • wilkinson99 | Send Message 18 Apr

                                    Premarket Top % Gainers: $IPI 16%, $DRIP 12%, $DWTI 11%, $GASX 10%, $BIOC 9%, $RUSS 7%, $NM 7%, $SCO $ERY $MNOV $ITUB $NMM $FCSC $ORPN $HAS
                                    Reply
                                      • bakerbros | Send Message 15 Apr

                                        I shorted $CRMD at $9, then covered near $4. I expect $MNOV to do the same.
                                        Reply
                                          Company Description
                                          MediciNova, Inc. operates as a biopharmaceutical company with interest in acquiring and developing novel, small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need with a specific focus on the U.S. market. The company's development... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States